NCT03567655View on ClinicalTrials.gov

Fertility-sparing Management Using High-dose Oral Progestin in Young Women With Endometrial Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

July 15, 2018

Primary Completion Date

October 31, 2022

Study Completion Date

November 30, 2022

Conditions
Endometrial Cancer
Interventions
DRUG

Farlutal tab. 500mg/ Pfizer

Medroxyprogesterone Acetate

Trial Locations (1)

138-736

Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Korean Gynecologic Oncology Group

OTHER

lead

Asan Medical Center

OTHER